NASDAQ:CTMX - CytomX Therapeutics SEC Filings & 10K Form

$10.81
+0.41 (+3.94 %)
(As of 06/17/2019 01:25 PM ET)
Today's Range
$10.30
Now: $10.81
$10.90
50-Day Range
$9.35
MA: $10.39
$11.36
52-Week Range
$8.94
Now: $10.81
$27.20
Volume116,178 shs
Average Volume291,447 shs
Market Capitalization$489.80 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5

SEC Filings

CytomX Therapeutics (NASDAQ:CTMX) SEC Filings

DateFilerForm TypeView
06/04/2019
3:06 PM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2019
3:04 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/31/2019
3:22 PM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
05/29/2019
5:06 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2019
11:27 AM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4/A
View Filing
05/09/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2019
3:06 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/02/2019
7:00 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2019
6:58 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/26/2019
2:49 PM
CytomX Therapeutics (Filer)
Form DEFA14A
View Filing
04/26/2019
2:46 PM
CytomX Therapeutics (Filer)
Form DEF 14A
View Filing
04/22/2019
3:16 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2019
7:52 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/10/2019
9:34 AM
CytomX Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
04/08/2019
3:07 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/25/2019
3:08 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/05/2019
1:57 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
3:40 PM
CytomX Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/26/2019
6:36 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
12:51 PM
CytomX Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
View Filing
02/13/2019
10:50 AM
CytomX Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
02/11/2019
11:15 PM
CytomX Therapeutics (Filer)
Form EFFECT
View Filing
02/06/2019
3:39 PM
CytomX Therapeutics (Filer)
Form S-3/A
View Filing
02/04/2019
9:07 AM
BlackRock Inc. (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
View Filing
01/31/2019
3:06 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/29/2019
6:01 PM
CytomX Therapeutics (Issuer)
Kavanaugh William Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
6:00 PM
CytomX Therapeutics (Issuer)
HUMPHREY RACHEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
5:58 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
5:57 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
5:56 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/27/2018
11:42 AM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/27/2018
11:40 AM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/20/2018
7:06 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/14/2018
2:23 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
12:57 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
12:55 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/19/2018
12:17 PM
CytomX Therapeutics (Filer)
Form CT ORDER
View Filing
11/19/2018
11:59 AM
CytomX Therapeutics (Filer)
Form CT ORDER
View Filing
11/06/2018
3:14 PM
CytomX Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
11/06/2018
3:07 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/06/2018
3:02 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/05/2018
3:15 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
3:14 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/22/2018
6:30 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
2:18 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/06/2018
6:18 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/06/2018
6:14 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:02 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/02/2018
7:55 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/17/2018
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2018
3:09 PM
CytomX Therapeutics (Filer)
Form 424B5
View Filing
07/10/2018
3:06 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/09/2018
5:15 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/06/2018
5:52 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
5:51 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
5:50 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
4:52 PM
CytomX Therapeutics (Issuer)
Fuchs Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
4:51 PM
CytomX Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
4:51 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/15/2018
4:49 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
4:47 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
4:47 PM
CytomX Therapeutics (Issuer)
SCARLETT JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:05 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/05/2018
6:46 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/05/2018
6:45 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
8:05 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2018
6:36 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/16/2018
4:02 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:05 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:03 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/02/2018
5:26 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2018
5:25 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
3:18 PM
CytomX Therapeutics (Filer)
Form DEF 14A
View Filing
04/04/2018
1:27 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/27/2018
7:54 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
4:28 PM
CytomX Therapeutics (Filer)
Form 10-K/A
View Filing
03/07/2018
3:47 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/07/2018
3:37 PM
CytomX Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/07/2018
3:19 PM
CytomX Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/05/2018
6:01 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2018
5:59 PM
CytomX Therapeutics (Issuer)
HUMPHREY RACHEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
10:55 AM
CytomX Therapeutics (Issuer)
HUMPHREY RACHEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
10:54 AM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
1:30 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
View Filing
02/13/2018
4:09 PM
CytomX Therapeutics (Subject)
PFIZER INC (Filed by)
Form SC 13G/A
View Filing
02/13/2018
3:17 PM
CytomX Therapeutics (Subject)
THIRD ROCK VENTURES LP (Filed by)
Form SC 13G/A
View Filing
02/12/2018
5:00 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
6:28 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
4:24 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/26/2018
3:52 PM
CytomX Therapeutics (Issuer)
HUMPHREY RACHEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
1:55 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
1:54 PM
CytomX Therapeutics (Issuer)
Kavanaugh William Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
1:53 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/09/2018
10:20 AM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
4:47 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
7:31 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2018
11:25 AM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
2:23 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/28/2017
4:56 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
11:23 AM
CytomX Therapeutics (Issuer)
HUMPHREY RACHEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel